Geoffrey M. Nichol
2013
In 2013, Geoffrey M. Nichol earned a total compensation of $1.7M as Executive Vice President, Research and Development at Sangamo Biosciences, a 30% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $255,094 |
|---|---|
| Option Awards | $598,878 |
| Salary | $453,500 |
| Stock Awards | $424,200 |
| Total | $1,731,672 |
Nichol received $598.9K in option awards, accounting for 35% of the total pay in 2013.
Nichol also received $255.1K in non-equity incentive plan, $453.5K in salary and $424.2K in stock awards.
Rankings
In 2013, Geoffrey M. Nichol's compensation ranked 4,393rd out of 12,286 executives tracked by ExecPay. In other words, Nichol earned more than 64.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,393 out of 12,286 | 64th |
Division Manufacturing | 1,506 out of 4,612 | 67th |
Major group Chemicals And Allied Products | 426 out of 1,462 | 71st |
Industry group Drugs | 293 out of 1,156 | 75th |
Industry Biological Products, Except Diagnostic Substances | 43 out of 196 | 78th |
Source: SEC filing on April 25, 2016.
Nichol's colleagues
We found four more compensation records of executives who worked with Geoffrey M. Nichol at Sangamo Biosciences in 2013.